Search details
1.
OpenPBTA: The Open Pediatric Brain Tumor Atlas.
Cell Genom
; 3(7): 100340, 2023 Jul 12.
Article
in English
| MEDLINE | ID: mdl-37492101
2.
Development of a pharmacologically improved peptide agonist of the leptin receptor.
Biochim Biophys Acta
; 1783(10): 1745-54, 2008 Oct.
Article
in English
| MEDLINE | ID: mdl-18555805
3.
YAP1 Mediates Resistance to MEK1/2 Inhibition in Neuroblastomas with Hyperactivated RAS Signaling.
Cancer Res
; 79(24): 6204-6214, 2019 12 15.
Article
in English
| MEDLINE | ID: mdl-31672841
4.
Posttranscriptional Regulation of PARG mRNA by HuR Facilitates DNA Repair and Resistance to PARP Inhibitors.
Cancer Res
; 77(18): 5011-5025, 2017 09 15.
Article
in English
| MEDLINE | ID: mdl-28687616
5.
Corrigendum: Designer Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models.
Front Mol Biosci
; 3: 75, 2016.
Article
in English
| MEDLINE | ID: mdl-27878121
6.
Designer Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models.
Front Mol Biosci
; 3: 67, 2016.
Article
in English
| MEDLINE | ID: mdl-27790618
7.
Exploring leptin antagonism in ophthalmic cell models.
PLoS One
; 8(10): e76437, 2013.
Article
in English
| MEDLINE | ID: mdl-24098500
8.
Peptide-based leptin receptor antagonists for cancer treatment and appetite regulation.
Biopolymers
; 96(2): 117-25, 2011.
Article
in English
| MEDLINE | ID: mdl-20564005
9.
Leptin-based therapeutics.
Expert Rev Endocrinol Metab
; 5(6): 875-889, 2010 Nov.
Article
in English
| MEDLINE | ID: mdl-30780830
10.
Leptin and its receptor are overexpressed in brain tumors and correlate with the degree of malignancy.
Brain Pathol
; 20(2): 481-9, 2010 Mar.
Article
in English
| MEDLINE | ID: mdl-19775291
Results
1 -
10
de 10
1
Next >
>>